Member Info for Qd22

Another huge market.

https://www.pv-magazine.com/2022/04/08/bosch-unveils-hydrogen-compatible-stationary-fuel-cell-system/

Agreed, topped up. From the March update:

"Our results for the year to 31 March 2022 are very much dependent on exactly which IP agreements we are able (and - dependent on terms - willing) to close in the next four weeks. If we do not conclude any large IP sales, we would expect overall revenues to be no less than £6m, with positive underlying EBITDA for the year. If this is indeed the outcome for the year, we would expect to conclude a number of IP sales in the first half of our next financial year.....

...We will report with as much detail as we can at year end on the progress of our licensees and partners."

Could we hear more soon? It's way, way down, so the sp looks like it may already be discounting no news. Some good news could take it right up again.

Really really hope we can stay independent. Do you want £x now, or £10x in 10 years?

And I really really really hope if we go we don't go to the Chinese. Their strategy for a long time has to get a monopoly in these strategic metals, and I can't remember the figures but they have at least a stranglehold now. A monopoly would be very bad news for all of us.

Looks like they are trying to cut costs, Gotrader. From Tuesday's results:

"In order to focus the business, longer term developments such as cREO® and Photonic Quasi Crystal are being de-prioritised in the short term to focus our development programmes on market driven solutions. IQE will retain the technology, capability and IP enabling redeployment if and when appropriate.

An exceptional intangible asset impairment charge of £7.4m has been recognised within the Reported Operating Loss. This comprises a non-cash impairment charge of £4.7m related to cREO® development costs and patents, following a decision to pause development activities on this technology until a commercial opportunity arises, in line with the markets based approach set out in our strategic priorities.A non-cash impairment charge of £2.7m has also been recognised for Quasi Photonic Crystal (QPC) and Diffusers, following a similar decision to suspend development activities.
Exceptional restructuring costs of £3.7m have been recognised in respect of site closures that are part of the Group’s global site optimisation programme."

Maybe that's why directors have been buying: they recognise that the new CEO is trying to run a business rather than chasing a dream?

2 massive trades after hours?? One for £2m.

Thank you

I've also been in here a long time - and so learnt some harsh lessons. Above all about myself.

Much as I want this to do well, I don't get what is slowly driving the SP upwards at the moment. Is it just that it dropped too far?

A nice problem to have:

"This new contract clearly has capacity and overhead implications. In several separate announcements, the Company has said that by mid 2023 we will have installed capacity for £50m sales p.a. which is enough to accommodate the extra volumes from this new contract. However, our staffing and infrastructure overheads are currently in line with the previous forecast of approximately £17m sales for 2023. Accordingly, the Company now needs to accelerate the recruitment and infrastructure actions required to support these much higher sales, which the Board currently estimates will result in current year overheads (mostly people related) increasing by £2.5m."

.... at 51.9p. Bit surprised at that price, seems scary low.

Ditto. Strange reaction (as usual) to great results.

Detecting 3 variants of concern. Can see that going down especially well in China - could sell like steamed buns.

I like the Skin Club model and growth. "Since the marketplace service opened in January, 82% of club members (around 1,500) who received Home Test Kit results have subsequently purchased recommended skincare products for their skin via the Skin Trust Club App." Impressive.

H2 revenue was £6m, and Q1 alone production orders are £5m, in just the environmental division, Modern Water.

So many small companies have great tech. So many have no sales. We have sales, in fact IMHO we're motoring.

My holding is small, but less small than it was this morning :)

Thanks Mafuta

Agreed that they are good results, and I am happy to be in here.

My only question is with regard to DermaPure, "dCELL® (DermaPure®) sales remained consistent at US$4.2m (2020: US$4.2m)". If sales of it to ARMS Medical were up 20%, where was the fall? And what is ARMS Medical?

With regard to the latter the half year report in September did have this:

"Product development

We completed development on two additional products and added them to our Biosurgery portfolio in H1 2021. The DermaPure Mesh, meshed dermal graft, was commercially introduced in June and VNEW®, a pre-shaped dermis graft, distributed through our urogynaecological partner, ARMS Medical, completed development with the first delivery to take place in Q3 2021."

Thank you are Oranolio1, that is very useful.

I get that it's still on the pricey side, I guess it always will be, but I really can't see the reason for the fall all the way from over 330 to this level, especially when it seemed to me the interims were cracking.

Great to get some good news today.

Does anyone have information wrt supply of aluminium? What I'm getting at is whether the sanctions and problems with Russia are going to affect the company. I've been searching the website, but without much success.

Think that was me! Just bought back in. NTQ has not been kind to me over the years, I first bought ages back, and finally sold out even lower than this a couple of years ago. But the issues you've noted are positive, it's well down, plus there is the geothermal side that they are beginning to identify themselves with strongly: "The RSS market has a global size of over $2bn and the SABER technology is targeted at a range of applications across the energy sector; geothermal drilling, methane capture and oil and gas operations." They may just be plugging the green face of an innately carbon producing industry participant, but geothermal does have potential, and they have the know how as much as anyone for the drilling.

Yes, this is exciting. Topped up at 114.2p. ImmunoInsights is going like the clappers, while for me the elephant in the corner is the early CDT lung (et al), which is progressing as fast as can be expected. Expecting contracts this year. Please don't buy us!

Surprised it's falling this morning on this news. Can see your point about the finance though, Trek. For me, if I wait I'll probably forget and miss it! Long term I can't see how this will not be a bargain.

ATB, everyone.

PS. We may have to kiss the CDT prospects in Russia farewell for now. :(